Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Usefulness of Computed Tomography and Cardiac Biomarkers in Risk Stratification of Aortic Stenosis

FY 2011-12

Summary
Cardiovascular disease is a leading cause of death in Canadian population. Aortic Stenosis is the third common cardiovascular disease after coronary artery disease and hypertension, making it the most frequent valvular disease in North America. Aortic Stenosis occurs when the heart's aortic valve narrows. This narrowing prevents the valve from opening fully, which obstructs blood flow from the heart into the aorta and onward to the rest of the body. When the aortic valve is obstructed, the heart needs to work harder to pump blood to the body. Eventually, this extra work limits the amount of blood it can pump and may weaken the heart muscle. If Aortic Stenosis is severe, the patient will usually need surgery to replace the valve. Left untreated, Aortic Stenosis can lead to serious heart problems and death. Doppler-echocardiography is the method of choice to assess the severity of valvular obstruction and the cardiac function in patients with Aortic Stenosis and decide when surgery is needed. But about 30% of the patients can't be well evaluated by Doppler-echocardiography and may be misdiagnosed and thus do not receive the appropriate therapies which would result in a poor outcome. The first objective of this prospective multicenter study is to develop and validate new indices to improve diagnostic and decision making in patients with Aortic Stenosis. We believe that other diagnosis exams, as computed tomography and analysis of cardiac hormone, may contribute to assess Aortic Stenosis severity and myocardial impairment and thus improve the risk stratification and outcome in Aortic Stenosis patients.
Program
CIHR Fellowship
Location
Minnesota, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
254021
Name
Clavel Marie-Annick
Region
Minnesota
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
Usefulness of Computed Tomography and Cardiac Biomarkers in Risk Stratification of Aortic Stenosis
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Aortic Stenosis; Cardiac Biomarkers; Computed Tomography; Diagnosis; Doppler-Echocardiography; Multimodality Imaging; Prognosis
Abstract
Cardiovascular disease is a leading cause of death in Canadian population. Aortic Stenosis is the third common cardiovascular disease after coronary artery disease and hypertension, making it the most frequent valvular disease in North America. Aortic Stenosis occurs when the heart's aortic valve narrows. This narrowing prevents the valve from opening fully, which obstructs blood flow from the heart into the aorta and onward to the rest of the body. When the aortic valve is obstructed, the heart needs to work harder to pump blood to the body. Eventually, this extra work limits the amount of blood it can pump and may weaken the heart muscle. If Aortic Stenosis is severe, the patient will usually need surgery to replace the valve. Left untreated, Aortic Stenosis can lead to serious heart problems and death. Doppler-echocardiography is the method of choice to assess the severity of valvular obstruction and the cardiac function in patients with Aortic Stenosis and decide when surgery is needed. But about 30% of the patients can't be well evaluated by Doppler-echocardiography and may be misdiagnosed and thus do not receive the appropriate therapies which would result in a poor outcome. The first objective of this prospective multicenter study is to develop and validate new indices to improve diagnostic and decision making in patients with Aortic Stenosis. We believe that other diagnosis exams, as computed tomography and analysis of cardiac hormone, may contribute to assess Aortic Stenosis severity and myocardial impairment and thus improve the risk stratification and outcome in Aortic Stenosis patients.
Competitiondate
201202
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Clavel, Marie-Annick
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~